Table 1.
Iclinical presentation | Management | Prevention |
---|---|---|
Mild acute mountain sickness Headahce with nausea, dizziness and fatigue during first 12 hrs after ascent to high altitude (> 3000 m) | Descend 500 m or more, rest and acclimatize; or speed acclimatization with acetazolamide (125-250 mg BD); or treat symptoms with analgesics and antiemetics | Ascend at a slow rate; spend a night at an intermediate altitude; avoid overexertion; avoid direct transport to an altitude of more than 3000 m; consider taking acetazolamide (125-250 mg BD) beginning on day before ascent and continuing for 2 days at high altitude |
Moderate acute mountain sickness Moderate to severe headache with marked nausea, dizziness, lassitude, insomnia, and fluid retention at high-altitude lasting for 12 hrs or more. | Descend 500m or more; if descent is not possible, use a hyperbaric chamber or administer low-flow oxygen (1-2 lts/min); if descent is not possible and oxygen is not available, administer acetazolamide (250 mg BD), or dexamethasone (4 mg PO or IM q 6 hourly), or both until symptoms resolve. | Ascend at a slow rate; spend a night at an intermediate altitude; avoid overexertion; avoid direct transport to an altitude of more than 3000m; consider taking acetazolamide (125-250 mg BD) beginning one day before ascent and continuing for 2 days at high-altitude; treat acute moutain sickness early. |
High-altitude cerebral oedema Acute Mountain Sickness for 24 hrs or more, severe lassitude, mental confusion, ataxia. | Initiate immediate descent or evacuation; if descent is not possible, use a portable hyperbaric chamber; administer oxygen (2-4 lts/min;) administer dexamethasone (8 mg PO or IM or IV initially and then 4 mg q 6 hourly); administer acetazolamide if descent is delayed. | Avoid direct transport to an altitude of more than 3000m; ascend at a slow rate; avoid overexertion; consider taking acetazolamide (125-250 mg BD) beginning one day before ascent and continuing for 2 days at high-altitude; treat acute mountain sickness early. |
High-altitude pulmonary oedema dyspnea at rest, moist cough, severe weakness, drowsiness, cyanosis, tachycardia, tachypnea rales. | Administer oxygen (4-6 lts/min until condition improves, and then 2-4 lts/min to conserve supplies); descend as soon as possible, with minimal exertion, or use a portable hyperbaric chamber; if descent is not possible or oxygen is not available, administer nifedipine (10 mg PO initially and then 30 mg of extended release formulations PO q 12-24 hrs); add dexamethasone if neurological deterioration occurs. | Ascend at a slow, graded rate; avoid overexertion; people with earlier episode should avoid high altitude areas. |
m – meters, PO – per orally, IM – Intra muscular, IV – Intra venous, BD -twice daily, lts – liters, q – each quantity, mg – milligrams, hrs – hours